Svær asthma bronchiale

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Svær asthma bronchiale. / von Bülow, Anna; Backer, Vibeke; Porsbjerg, Celeste.

I: Ugeskrift for Laeger, Bind 177, Nr. 1, V05130307, 2015, s. 52-56.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

von Bülow, A, Backer, V & Porsbjerg, C 2015, 'Svær asthma bronchiale', Ugeskrift for Laeger, bind 177, nr. 1, V05130307, s. 52-56.

APA

von Bülow, A., Backer, V., & Porsbjerg, C. (2015). Svær asthma bronchiale. Ugeskrift for Laeger, 177(1), 52-56. [V05130307].

Vancouver

von Bülow A, Backer V, Porsbjerg C. Svær asthma bronchiale. Ugeskrift for Laeger. 2015;177(1):52-56. V05130307.

Author

von Bülow, Anna ; Backer, Vibeke ; Porsbjerg, Celeste. / Svær asthma bronchiale. I: Ugeskrift for Laeger. 2015 ; Bind 177, Nr. 1. s. 52-56.

Bibtex

@article{fce30d5845434a0c92de3ebb4f97fd76,
title = "Sv{\ae}r asthma bronchiale",
abstract = "Severe asthma is defined by persistent symptoms and frequent exacerbations despite intensive asthma therapy. The prevalence is estimated to be 5-10% of all asthmatics. Severe asthma is responsible for a major burden of illness including low quality of life and a disproportionate use of health-care resources. The clinical assessment of severe asthma must include verification of the correct diagnosis, adherence to medication, excluding differential diagnosis and identification and treatment of aggravating co-morbidities and trigger factors.",
author = "{von B{\"u}low}, Anna and Vibeke Backer and Celeste Porsbjerg",
year = "2015",
language = "Dansk",
volume = "177",
pages = "52--56",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "1",

}

RIS

TY - JOUR

T1 - Svær asthma bronchiale

AU - von Bülow, Anna

AU - Backer, Vibeke

AU - Porsbjerg, Celeste

PY - 2015

Y1 - 2015

N2 - Severe asthma is defined by persistent symptoms and frequent exacerbations despite intensive asthma therapy. The prevalence is estimated to be 5-10% of all asthmatics. Severe asthma is responsible for a major burden of illness including low quality of life and a disproportionate use of health-care resources. The clinical assessment of severe asthma must include verification of the correct diagnosis, adherence to medication, excluding differential diagnosis and identification and treatment of aggravating co-morbidities and trigger factors.

AB - Severe asthma is defined by persistent symptoms and frequent exacerbations despite intensive asthma therapy. The prevalence is estimated to be 5-10% of all asthmatics. Severe asthma is responsible for a major burden of illness including low quality of life and a disproportionate use of health-care resources. The clinical assessment of severe asthma must include verification of the correct diagnosis, adherence to medication, excluding differential diagnosis and identification and treatment of aggravating co-morbidities and trigger factors.

M3 - Tidsskriftartikel

C2 - 25347175

VL - 177

SP - 52

EP - 56

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 1

M1 - V05130307

ER -

ID: 137511851